These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16008600)

  • 1. Increased risk of post-transplant diabetes mellitus despite early steroid discontinuation in Hispanic kidney transplant recipients.
    Walczak DA; Calvert D; Jarzembowski TM; Testa G; Sankary HN; Thielke J; Oberholzer J; Benedetti E
    Clin Transplant; 2005 Aug; 19(4):527-31. PubMed ID: 16008600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of race on the occurrence of posttransplant diabetes in kidney transplant recipients treated with early steroid discontinuation.
    Walczak D; Calvert D; Oberholzer J; Testa G; Sankary H; Benedetti E
    Transplant Proc; 2005 Mar; 37(2):819-21. PubMed ID: 15848543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ
    Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid minimization in liver transplant recipients: impact on hepatitis C recurrence and post-transplant diabetes.
    Humar A; Crotteau S; Gruessner A; Kandaswamy R; Gruessner R; Payne W; Lake J
    Clin Transplant; 2007; 21(4):526-31. PubMed ID: 17645714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid avoidance immunosuppression in low-risk kidney transplant recipients.
    Heilman RL; Mazur MJ; Reddy KS; Moss A; Post D; Mulligan D
    Transplant Proc; 2005 May; 37(4):1785-8. PubMed ID: 15919466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs.
    Araki M; Flechner SM; Ismail HR; Flechner LM; Zhou L; Derweesh IH; Goldfarb D; Modlin C; Novick AC; Faiman C
    Transplantation; 2006 Feb; 81(3):335-41. PubMed ID: 16477217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transplant diabetes mellitus: is it associated with poor allograft outcomes in renal transplants?
    Choi JY; Kwon OJ
    Transplant Proc; 2013 Oct; 45(8):2892-8. PubMed ID: 24156999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients.
    Oberholzer J; John E; Lumpaopong A; Testa G; Sankary HN; Briars L; Kraft KA; Knight PS; Verghese P; Benedetti E
    Pediatr Transplant; 2005 Aug; 9(4):456-63. PubMed ID: 16048597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic evaluation of short-term outcome after early corticosteroid discontinuation in kidney transplantation.
    Miura M; Ogawa Y; Kubota KC; Harada H; Shimoda N; Seki T; Hirano T; Nonomura K
    Clin Transplant; 2009 Aug; 23 Suppl 20():10-6. PubMed ID: 19594589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid-avoidance immunosuppression regimen in live-donor renal allotransplant recipients: a prospective, randomized, controlled study.
    Nematalla AH; Bakr MA; Gheith OA; Elagroudy AE; Elshahawy el-M; Aghoneim M
    Exp Clin Transplant; 2007 Dec; 5(2):673-9. PubMed ID: 18194120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-Transplant Diabetes Mellitus After Kidney Transplant in Hispanics and Caucasians Treated with Tacrolimus-Based Immunosuppression.
    Baron PW; Infante S; Peters R; Tilahun J; Weissman J; Delgado L; Kore AH; Beeson WL; de Vera ME
    Ann Transplant; 2017 May; 22():309-314. PubMed ID: 28533501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excellent clinical outcomes in primary kidney transplant recipients treated with steroid-free maintenance immunosuppression.
    Rajab A; Pelletier RP; Henry ML; Ferguson RM
    Clin Transplant; 2006; 20(5):537-46. PubMed ID: 16968478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years.
    Cosio FG; Pesavento TE; Osei K; Henry ML; Ferguson RM
    Kidney Int; 2001 Feb; 59(2):732-7. PubMed ID: 11168956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study.
    Gnatta D; Keitel E; Heineck I; Cardoso BD; Rodrigues AP; Michel K; Garcia VD
    Transplant Proc; 2010 Mar; 42(2):475-8. PubMed ID: 20304169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcineurin inhibitor avoidance versus steroid avoidance following kidney transplantation: Postoperative complications.
    Shaffer D; Kizilisik AT; Feurer I; Nylander WA; Helderman JH; Langone AJ; Schaefer HM
    Transplant Proc; 2006 Dec; 38(10):3464-5. PubMed ID: 17175304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High impact of rejection therapy on the incidence of post-transplant diabetes mellitus after kidney transplantation.
    Schweer T; Gwinner W; Scheffner I; Schwarz A; Haller H; Blume C
    Clin Transplant; 2014 Apr; 28(4):512-9. PubMed ID: 24649873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage.
    Liu CL; Fan ST; Lo CM; Chan SC; Ng IO; Lai CL; Wong J
    Liver Transpl; 2004 Jun; 10(6):728-33. PubMed ID: 15162466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial.
    Zuckermann A; Reichenspurner H; Birsan T; Treede H; Deviatko E; Reichart B; Klepetko W
    J Thorac Cardiovasc Surg; 2003 Apr; 125(4):891-900. PubMed ID: 12698153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New-onset diabetes mellitus after kidney transplantation: the role of immunosuppression.
    Veroux M; Corona D; Giuffrida G; Gagliano M; Sorbello M; Virgilio C; Tallarita T; Zerbo D; Giaquinta A; Fiamingo P; Macarone M; Li Volti G; Caglia P; Veroux P
    Transplant Proc; 2008; 40(6):1885-7. PubMed ID: 18675079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.